Osiris Therapeutics Inc. isn’t making any promises that it will meet the latest deadline handed down by the Nasdaq Stock Exchange to get current with its financial reporting. A Nasdaq Stock Exchange hearings panel has decided to give the Columbia biotech until March 10 to become current with its financial filings with the U.S. Securities and Exchange Commission, according to federal documents filed late Friday. If Osiris fails it will be delisted from the Nasdaq. “There can be no assurance regarding…
from http://www.bizjournals.com/baltimore/news/2016/12/05/osiris-therapeutics-could-be-delisted-from-nasdaq.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/154079561242
No comments:
Post a Comment